[go: up one dir, main page]

MX2019009384A - Composiciones generadoras de gastrotransmisores electroquimicos y sus metodos de uso y apositos y sistemas de tratamiento que los incorporan. - Google Patents

Composiciones generadoras de gastrotransmisores electroquimicos y sus metodos de uso y apositos y sistemas de tratamiento que los incorporan.

Info

Publication number
MX2019009384A
MX2019009384A MX2019009384A MX2019009384A MX2019009384A MX 2019009384 A MX2019009384 A MX 2019009384A MX 2019009384 A MX2019009384 A MX 2019009384A MX 2019009384 A MX2019009384 A MX 2019009384A MX 2019009384 A MX2019009384 A MX 2019009384A
Authority
MX
Mexico
Prior art keywords
methods
gasotransmitter
dressings
compositions
transmitters
Prior art date
Application number
MX2019009384A
Other languages
English (en)
Other versions
MX389787B (es
Inventor
Samuel Stevan
Willey Alan
Original Assignee
Noxsano Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noxsano Inc filed Critical Noxsano Inc
Publication of MX2019009384A publication Critical patent/MX2019009384A/es
Publication of MX389787B publication Critical patent/MX389787B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/48—Sulfur dioxide; Sulfurous acid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/50—Nitrous acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones que comprenden un mediador electroquímico orgánico y una sal de gasotransmisor que se convierte en un gasotransmisor mediante transferencia de electrones. También se describen vendajes y apósitos para heridas que comprenden los gasotransmisores sujetos, y métodos para fabricar un gasotransmisor, que comprenden exponer 5 las composiciones a un voltaje suficiente para reducir el mediador orgánico soluble en agua. Además, se describen métodos para tratar una variedad de estados de trauma y enfermedad aplicando una cantidad terapéuticamente efectiva de al menos un gasotransmisor a los mismos, y métodos para generar una dosis efectiva del gasotransmisor generado a partir de una reacción electrolítica que involucra las composiciones generadoras de gasotransmisores.
MX2019009384A 2017-02-09 2018-01-18 Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan. MX389787B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762457039P 2017-02-09 2017-02-09
PCT/US2018/014265 WO2018147986A1 (en) 2017-02-09 2018-01-18 Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same

Publications (2)

Publication Number Publication Date
MX2019009384A true MX2019009384A (es) 2019-12-11
MX389787B MX389787B (es) 2025-03-19

Family

ID=63038868

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009384A MX389787B (es) 2017-02-09 2018-01-18 Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan.

Country Status (14)

Country Link
US (1) US10342706B2 (es)
EP (1) EP3579888B1 (es)
JP (1) JP6989157B2 (es)
KR (1) KR102189597B1 (es)
CN (1) CN110461374B (es)
AU (1) AU2018218200B2 (es)
CA (1) CA3053141A1 (es)
CL (1) CL2019002220A1 (es)
ES (1) ES2965705T3 (es)
IL (1) IL268577B (es)
MX (1) MX389787B (es)
PL (1) PL3579888T3 (es)
WO (1) WO2018147986A1 (es)
ZA (1) ZA201905431B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190328774A1 (en) * 2017-02-09 2019-10-31 Noxsano Inc. Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
AU2019261383A1 (en) * 2018-04-25 2020-11-12 Noxsano Inc. Light activated gasotransmitter generating compositions
US11576929B2 (en) 2018-06-08 2023-02-14 Sumitomo Seika Chemicals Co., Ltd. Composition for inflammatory gastrointestinal disorders
US20210228621A1 (en) * 2018-06-08 2021-07-29 Sumitomo Seika Chemicals Co., Ltd. Composition for skin wounds
JP2022517208A (ja) * 2019-01-11 2022-03-07 ノクサノ インコーポレイテッド ガス状伝達物質を生成するための電気化学ガス状伝達物質生成組成物及びバイメタル電池
TWI694844B (zh) * 2019-01-29 2020-06-01 明基材料股份有限公司 硫化氫緩釋敷料及其製造方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料（芜湖）有限公司 硫化氢缓释敷料及其制造方法
WO2020245574A1 (en) * 2019-06-04 2020-12-10 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
EP3980373A1 (en) * 2019-06-04 2022-04-13 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
WO2021152504A1 (en) * 2020-01-30 2021-08-05 3M Innovative Properties Company Delivery system for aqueous zinc oral care compositions with fluoride
CN115382095B (zh) * 2022-08-21 2025-08-08 兰州理工大学 超级电容器、应用超级电容器的伤口敷料，以及制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US20090036516A1 (en) * 2003-01-13 2009-02-05 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome
NZ575671A (en) * 2006-10-05 2011-04-29 Ikaria Inc Liquid chalcogenide compositions and methods of manufacturing and using the same
US20110104240A1 (en) * 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
EP2519297A4 (en) * 2009-12-31 2013-08-21 Univ Ohio SYSTEMS AND METHOD FOR PROMOTING WOUND HEALING
EP2755620A4 (en) * 2011-09-14 2015-06-03 3M Innovative Properties Co POSITIVE PRESSURE MEDICAL DRESSINGS HAVING VALVE AND KIT CONTAINING SAME
BR112014004859A2 (pt) * 2011-09-14 2017-06-13 Univ Emory preparação e composições de enxofre zerovalente altamente biodisponíveis e usos das mesmas
US9480785B2 (en) * 2012-03-30 2016-11-01 The Regents Of The University Of Michigan Nitric oxide delivery devices
US9498571B2 (en) * 2012-03-30 2016-11-22 The Regents Of The University Of Michigan Nitric oxide delivery devices
BR102013022095A2 (pt) 2013-08-29 2016-08-02 Mineração Tabiporã Ltda processo para a obtenção de sulfeto de hidrogênio a partir da redução de sulfato de cálcio e da decomposição do sulfeto de cálcio com cloreto de magnésio
WO2015067746A1 (de) * 2013-11-07 2015-05-14 Bsn Medical Gmbh Medizinische auflage

Also Published As

Publication number Publication date
WO2018147986A1 (en) 2018-08-16
EP3579888C0 (en) 2023-09-27
ZA201905431B (en) 2020-05-27
KR102189597B1 (ko) 2020-12-14
PL3579888T3 (pl) 2024-05-27
MX389787B (es) 2025-03-19
CN110461374A (zh) 2019-11-15
AU2018218200B2 (en) 2023-11-23
IL268577B (en) 2020-03-31
US20180221210A1 (en) 2018-08-09
ES2965705T3 (es) 2024-04-16
CN110461374B (zh) 2022-05-31
AU2018218200A1 (en) 2019-08-29
US10342706B2 (en) 2019-07-09
JP6989157B2 (ja) 2022-01-05
JP2020511526A (ja) 2020-04-16
CL2019002220A1 (es) 2020-01-03
EP3579888A4 (en) 2021-04-07
EP3579888A1 (en) 2019-12-18
BR112019016486A2 (pt) 2020-04-07
EP3579888B1 (en) 2023-09-27
CA3053141A1 (en) 2018-08-16
KR20190108169A (ko) 2019-09-23
IL268577A (en) 2019-09-26

Similar Documents

Publication Publication Date Title
MX2019009384A (es) Composiciones generadoras de gastrotransmisores electroquimicos y sus metodos de uso y apositos y sistemas de tratamiento que los incorporan.
MX2021005898A (es) Terapia de combinacion que incluye un inhibidor de krasg12c y uno o mas agentes farmaceuticamente activos adicionales para el tratamiento de canceres.
MX2020007060A (es) Compuestos, composiciones y metodos para tratar enfermedades que involucren tejidos con enfermedades acidas o hipoxicas.
UY38160A (es) Partículas implantables y métodos relacionados
CO2020009225A2 (es) Análogos de dihidrobenzofurano e indeno como inhibidores del sarcómero cardíaco
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
ECSP20029790A (es) Compuestos moduladores de sting y métodos de elaboración y uso
JOP20210244A1 (ar) مركبات وتركيبات وطرائق لمعالجة الأمراض
CL2018001145A1 (es) Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
DOP2024000039A (es) Derivados de quinolina como inhibidores de la integrina alfa4beta7
MX2015011478A (es) Compuestos de amida para el tratamiento de vih.
CO2021012579A2 (es) Compuestos útiles en la terapia del vih
CL2019003515A1 (es) Compuestos heteroaromáticos como inhibidores de vanina.
MX2021015543A (es) Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo.
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
CL2019003486A1 (es) Compuestos que contienen nitrogeno sustituido.
ECSP19026973A (es) Derivados de naftiridinona y su uso en el tratamiento de la arritmia
CL2021000329A1 (es) Compuestos útiles en terapia del vih
MX375118B (es) Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1.
MX2021007161A (es) Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia.
PE20181450A1 (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
MX2016015106A (es) Derivados de dipicolilamina y sus usos farmaceuticos.
MX2017009863A (es) Agente preventivo y/o terapeutico de enfermedad inmune.
CL2021003275A1 (es) Compuestos para tratar enfermedad respiratoria.